Risk factors associated with short-term post-treatment outcomes of clinical mastitis
Authors:
- P.L. RueggPRP.L. Ruegg
- 1 July 2011
- journal article
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 94 (7) , 3397-3410
Abstract
The objectives of this study were to characterize 60-d outcomes after treatment of mild (abnormal milk) and moderate (abnormal milk and abnormal udder) cases of clinical mastitis (CM) occurring in a single quarter of cows on Wisconsin farms (n=4) and to determine risk factors associated with those outcomes. Duplicate milk samples were collected from the affected quarter of each cow for microbiological analysis at the onset of CM (PRE) and 21 d later (POST). Cows were treated only in the affected quarter using an intramammary product containing 125 mg of ceftiofur. Bacteriological cure was defined as absence of pathogens in the POST sample obtained from the enrolled quarter. Recurrence was defined for the cow when CM occurred after the milk-withholding period for the enrolled case of CM. Retention in the herd was defined when a cow was retained within the herd for the 60-d follow-up period. Somatic cell count reduction (SCCR) was defined at the cow level as somatic cell count (SCC) below 200,000 cells/mL at the Dairy Herd Improvement Association test day occurring between 21 to 55 d post-treatment. The effects of farm, days in milk, parity, severity, microbiological diagnosis at PRE, previous milk yield, previous SCC, previous occurrence of CM and treatment duration on selected post-treatment outcomes were assessed using Chi-squared analysis and logistic regression. Microbiological results at PRE were distributed as: Escherichia coli (n=14), Klebsiella spp. (n=11), Enterobacter spp. (n=8), Serratia spp. (n=7), other gram-negative species (n=3), Streptococcus spp. (n=25), coagulase-negative staphylococci (n=4); Staphylococcus aureus (n=1); Streptococcus agalactiae (n=1), other gram-positive species (n=9), and culture negative (n=60). Treated quarters were more likely to experience bacteriological cure when the cow experienced CM for the first time in the lactation and when no pathogen was recovered from PRE milk samples obtained from the enrolled quarter. Parity and bacteriological cure were associated with the probability of recurrence. Greater milk yield at previous Dairy Herd Improvement test was the most important predictor for retention within the herd. When SCC before CM was >200,000 cells/mL the probability of having SCCR after treatment was decreased. When the case experienced bacteriological cure, the cow was less likely to experience recurrent cases and was more likely to have SCCR below 200,000 cells/mL. Post-treatment outcomes, such as recurrence and SCCR, are strongly associated with bacteriological cure and, when monitored, can be used to help determine if a treatment has been successful. Information about the etiology of CM, history of clinical and subclinical mastitis, and parity are useful to review when making strategic treatment decisions.Keywords
This publication has 35 references indexed in Scilit:
- Diagnosing intramammary infections: Evaluating expert opinions on the definition of intramammary infection using conjoint analysisJournal of Dairy Science, 2010
- Relationship between in vitro susceptibility test results and treatment outcomes for gram-positive mastitis pathogens following treatment with cephapirin sodiumJournal of Dairy Science, 2009
- Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparationsJournal of Dairy Science, 2009
- Effect of Repeated Episodes of Generic Clinical Mastitis on Milk Yield in Dairy CowsJournal of Dairy Science, 2007
- Invited Review: The Role of Cow, Pathogen, and Treatment Regimen in the Therapeutic Success of Bovine Staphylococcus aureus MastitisJournal of Dairy Science, 2006
- Factors Affecting Cure and Somatic Cell Count After Pirlimycin Treatment of Subclinical Mastitis in Lactating CowsJournal of Dairy Science, 2005
- Associations Between Pathogen-Specific Cases of Clinical Mastitis and Somatic Cell Count PatternsJournal of Dairy Science, 2004
- Mastitis therapy and pharmacologyVeterinary Clinics of North America: Food Animal Practice, 2003
- Treatment of clinical mastitisVeterinary Clinics of North America: Food Animal Practice, 2003
- Use of Augmented Cultural Techniques in the Diagnosis of the Bacterial Cause of Clinical Bovine MastitisJournal of Dairy Science, 1992